Literature DB >> 15797660

Lack of agreement between office and ambulatory blood pressure responses to hydrochlorothiazide.

Javier Daniel Finkielman1, Gary L Schwartz, Arlene B Chapman, Eric Boerwinkle, Stephen T Turner.   

Abstract

BACKGROUND: Differences between the antihypertensive responses to drug therapy measured by office blood pressure (OBP) and ambulatory blood pressure monitoring (ABPM) techniques have been noted but rarely analyzed. We studied whether the OBP and 24-h ABPM responses to hydrochlorothiazide differ and, if so, the relevance of these differences.
METHODS: The OBP and ABPM responses to hydrochlorothiazide (25 mg/d, for 4 weeks) were measured in 228 subjects with essential hypertension, and mean responses were compared between methods using the Student paired t test. To assess variation in the agreement between OBP and ABPM responses among subjects, the limits of agreement were calculated as the mean difference between OBP and ABPM responses +/-2 standard deviations.
RESULTS: The mean systolic OBP response was 4.8 mm Hg greater than the response measured by ABPM (-14.3 v -9.5 mm Hg, P < .001), and the mean diastolic OBP response was 2.1 mm Hg greater than the response measured by ABPM (-7.5 v -5.5, P < .001). The limits of agreement between the OBP and ABPM responses ranged from -18.7 to +28.2 mm Hg for systolic response and from -12.9 to +17.1 mm Hg for diastolic response. The systolic and diastolic OBP and ABPM responses were in opposite directions in 22.8% and 23.7% of the subjects, respectively.
CONCLUSIONS: Compared to ABPM, OBP overestimates the mean systolic and mean diastolic blood pressure responses to hydrochlorothiazide. Variation among subjects in the magnitude and direction of responses renders OBP an unreliable predictor of ABPM responses.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15797660     DOI: 10.1016/j.amjhyper.2004.10.021

Source DB:  PubMed          Journal:  Am J Hypertens        ISSN: 0895-7061            Impact factor:   2.689


  8 in total

Review 1.  The pharmacogenetics research network: from SNP discovery to clinical drug response.

Authors:  K M Giacomini; C M Brett; R B Altman; N L Benowitz; M E Dolan; D A Flockhart; J A Johnson; D F Hayes; T Klein; R M Krauss; D L Kroetz; H L McLeod; A T Nguyen; M J Ratain; M V Relling; V Reus; D M Roden; C A Schaefer; A R Shuldiner; T Skaar; K Tantisira; R F Tyndale; L Wang; R M Weinshilboum; S T Weiss; I Zineh
Journal:  Clin Pharmacol Ther       Date:  2007-03       Impact factor: 6.875

2.  Pharmacist-physician comanagement of hypertension and reduction in 24-hour ambulatory blood pressures.

Authors:  Cynthia A Weber; Michael E Ernst; Genesis S Sezate; Shimin Zheng; Barry L Carter
Journal:  Arch Intern Med       Date:  2010-10-11

3.  Pharmacogenomics of antihypertensive drugs: rationale and design of the Pharmacogenomic Evaluation of Antihypertensive Responses (PEAR) study.

Authors:  Julie A Johnson; Eric Boerwinkle; Issam Zineh; Arlene B Chapman; Kent Bailey; Rhonda M Cooper-DeHoff; John Gums; R Whit Curry; Yan Gong; Amber L Beitelshees; Gary Schwartz; Stephen T Turner
Journal:  Am Heart J       Date:  2009-03       Impact factor: 4.749

4.  Pharmacogenomic studies of hypertension: paving the way for personalized antihypertensive treatment.

Authors:  Michael T Eadon; Sri H Kanuri; Arlene B Chapman
Journal:  Expert Rev Precis Med Drug Dev       Date:  2018-01-03

5.  All thiazide-like diuretics are not chlorthalidone: putting the ACCOMPLISH study into perspective.

Authors:  Michael E Ernst; Barry L Carter; Jan N Basile
Journal:  J Clin Hypertens (Greenwich)       Date:  2009-01       Impact factor: 3.738

6.  Power to identify a genetic predictor of antihypertensive drug response using different methods to measure blood pressure response.

Authors:  Stephen T Turner; Gary L Schwartz; Arlene B Chapman; Amber L Beitelshees; John G Gums; Rhonda M Cooper-Dehoff; Eric Boerwinkle; Julie A Johnson; Kent R Bailey
Journal:  J Transl Med       Date:  2012-03-13       Impact factor: 5.531

7.  Comparison of office, ambulatory, and home blood pressure antihypertensive response to atenolol and hydrochlorthiazide.

Authors:  Amber L Beitelshees; Yan Gong; Kent R Bailey; Stephen T Turner; Arlene B Chapman; Gary L Schwartz; John G Gums; Eric Boerwinkle; Julie A Johnson
Journal:  J Clin Hypertens (Greenwich)       Date:  2010-01       Impact factor: 3.738

8.  Randomized, Double-Blind Clinical Trial to Assess the Acute Diuretic Effect of Equisetum arvense (Field Horsetail) in Healthy Volunteers.

Authors:  Danilo Maciel Carneiro; Ramias Calixto Freire; Tereza Cristina de Deus Honório; Iury Zoghaib; Fabiana Fernandes de S E Silva Cardoso; Leonice Manrique F Tresvenzol; José Realino de Paula; Ana Luiza Lima Sousa; Paulo César Brandão Veiga Jardim; Luiz Carlos da Cunha
Journal:  Evid Based Complement Alternat Med       Date:  2014-03-04       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.